Eurogin is part of the Informa Markets Division of Informa PLC

Informa
Informa

Abstract Submission is open! Submit by October 15, 2023

EUROGIN Program Highlights

A full overview of current scientific developments in the field of cervical cancer and other HPV related diseases

High-level Scientific Program

EUROGIN focuses on translating scientific and evidence-based research into clinical practice by offering a high quality and innovative scientific program drawn up by outstanding international leaders from the academic sector as well as professional and patient organizations. 

The program aims to foster future advancements by providing fundamental insights to physicians and young researchers.

60+ Scientific Sessions

A series of scientific sessions presenting the latest research

180+ Faculty Members

World class speakers presenting the most pressing issues in the field of HPV and related-cancers 

6 Satellite Symposia

Organized by industry partners presenting the most recent findings, innovations and future developments

What not to miss at EUROGIN

HPV and Head & Neck Forum

The EUROGIN HPV and Head & Neck Cancer Forum will highlight recent advances and areas of active research in the field of HPV-related head and neck cancers.

Cervical Cancer Screening Workshop

This workshop will provide more insight into the transition from research to implementation on the basis of 3 potential new screening technologies on the roadmap to eliminate cervical cancer: HPV-screening, self-sampling and methylation.

2023 Workshop HPV France

Élimination du cancer du col utérin en marche
Comment la France peut parvenir à une stratégie nationale d’élimination des cancers HPV-induits ?

spain

2023 Programa Workshop AEPCC

For the 2023 edition of EUROGIN, we have a half-day local workshop, in Spanish, conducted in association with “Asociación Española de Patología Cervical y Colposcopia” that will shed light on the latest in HPV scientific research.

The EUROGIN congress offers a full overview of current scientific developments in the field of cervical cancer and other HPV related diseases control with a program informed by leading scientists.